BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18327996)

  • 1. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
    Davidson MH
    Am J Cardiol; 2004 Jun; 93(11A):3C-11C. PubMed ID: 15178511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
    Brown BG; Zhao XQ
    Am J Cardiol; 2008 Apr; 101(8A):58B-62B. PubMed ID: 18375243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
    Goldberg RB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of dyslipidemia in primary care.
    Alzahrani T; Marrat S; Haider A
    Can J Cardiol; 2003 Dec; 19(13):1499-502. PubMed ID: 14760440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening and treatment of hyperlipidemias in Israel].
    Sehayek E; Eisenberg S
    Harefuah; 1995 May; 128(9):529-32, 600. PubMed ID: 7797148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS
    Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of diabetic dyslipidemia.
    Del Pilar Solano M; Goldberg RB
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):1-25, v. PubMed ID: 15752919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes.
    Maahs DM; Wadwa RP; McFann K; Nadeau K; Williams MR; Eckel RH; Klingensmith GJ
    J Pediatr; 2007 Feb; 150(2):146-50, 150.e1-2. PubMed ID: 17236891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update of lipid lowering therapy].
    Riesen WF; Mordasini RC
    Praxis (Bern 1994); 2008 Nov; 97(22):1179-84. PubMed ID: 18979436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

  • 18. Identifying all suspects: case studies.
    Mason CM
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S307-16. PubMed ID: 11517817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.